Search clinical trials for: TAk-935

Total 1342 results

Takeda
COUR Pharmaceuticals Development Company, Inc.

Completed

Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease

Celiac Disease

United States
He Eye Hospital

Unknown

Branch Retinal Vein Occlusion (BRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.

Branch Retinal Vein Occlusion

China
Kyungpook National University Hospital

Completed

Retinal Vessel Diameter in Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion

Korea, Republic of
Takeda

Completed

Long-term Study of TAK-875

Diabetes Mellitus

Japan
Fukushima Medical University

Unknown

Retinal Sensitivity in BRVO After Anti-VEGF Therapy

Branch Retinal Vein Occlusion

Japan
University of Leipzig

Completed

Neuron Specific Enolase (NSE) as Outcome Parameter of Cooling Therapy After Survived Sudden Cardiac Death

Cardiac Arrest | Hypothermia

Germany
Takeda

Recruiting

A Study of TAK-279 in Adults With or Without Liver Damage

Healthy Volunteers | Hepatic Impairment

United States
Takeda

Completed

A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy

Gastric Ulcer | Duodenal Ulcer

Japan
Takeda

Terminated

TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes

Diabetes

United States, Peru, Argentina
Avera McKennan Hospital & University Health Center

Active, not recruiting

Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid Tumors

Advanced Solid Tumor

United States
ANRS, Emerging Infectious Diseases
Aix Marseille Université; Fondation de France; Université du Québec a Montréal; Centre Population et Développement (CEPED), Paris, France and other collaborators

Unknown

ANRS12373 GUNDO SO - Evaluation of an Empowerment Program for WLHIV in Mali

HIV/AIDS | HIV Seropositivity | Empowerment | Disclosure

Mali
The Catholic University of Korea

Completed

Adenoma Detection by Polypectomy During Both Insertion and Withdrawal

Adenoma of Large Intestine
Swiss Group for Clinical Cancer Research

Withdrawn

Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents

Prostate Cancer

Switzerland
The University of Hong Kong
Health and Medical Research Fund

Recruiting

Development of Typology-based Smoking Relapse Prevention: A Q-methodology and a Pilot Randomized Controlled Trial

Smoking Cessation

Hong Kong
National Cancer Center, Korea

Unknown

MAC Bipsectral Index Below 50 for Chronic Opioid User

Anesthesia

Korea, Republic of
The University of Hong Kong
Health and Medical Research Fund

Recruiting

Quit Smoking: Optimizing Health Promotion Strategy

Smoking Cessation

Hong Kong
Takeda

Terminated

A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism

Hypogonadotropic Hypogonadism

United Kingdom
Regeneron Pharmaceuticals
Bayer

Completed

Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO) (VIBRANT)

Branch Retinal Vein Occlusion

United States, Japan, Canada
Takeda

Terminated

Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Poland, Bulgaria, Romania, Canada, Hungary, Slovakia
Takeda

Withdrawn

A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 Disorder

Bipolar Disorder
Khyber Medical University Peshawar

Completed

Effect of Barley Supplemented Wheat Bread on Markers of Cardiovascular and Renal Health

Cardiovascular Diseases | Kidney Diseases

Pakistan
UCB Biopharma SRL

Completed

A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis

Ankylosing Spondylitis

United States, Czechia, Germany, Greece, Moldova, Republic of, Netherlands, Poland, Russian Federation
Novartis Pharmaceuticals

Completed

16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis (MEASURE 1)

Ankylosing Spondylitis

Germany, Belgium, Netherlands, France, United States, Bulgaria, Italy, Russian Federation, Peru, United Kingdom, Canada, Mexico, Taiwan, Turkey
Kwang Dong Pharmaceutical co., ltd.

Recruiting

A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)

Hypoactive Sexual Desire Disorder

Korea, Republic of
Hong Kong Sanatorium & Hospital
Chinese University of Hong Kong

Terminated

Pilot Study on Traditional Chinese Medicine and Food Allergy (TCMFA)

Allergy to Fish | Allergy to Shrimp | Allergy to Crab

Hong Kong
Lallemand Pharma AG

Completed

Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK)

Allergy | Common Cold

Poland
Takeda

Terminated

TAK-071 Scopolamine-Induced Cognitive Impairment Study

Healthy Volunteers

United States
Takeda

Completed

Study of TAK-816 in Healthy Infants

Immunization

Japan
Swiss Group for Clinical Cancer Research

Completed

Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy

Prostate Cancer

Switzerland
Takeda

Recruiting

A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in India

Healthy Volunteers

India
University of Oxford
Mahidol Oxford Tropical Medicine Research Unit; Shoklo Malaria Research Unit... and other collaborators

Recruiting

Causes and Outcomes of Febrile Illness in Health Facilities in Rural South and Southeast Asia (SEACTN-WP-B)

Acute Febrile Illness

Bangladesh, Lao People's Democratic Republic, Thailand
Takeda

Recruiting

A Study About Fazirsiran in People With and Without Liver Problems

Hepatic Impairment

Hungary, Slovakia
Northwestern University
National Institute of Mental Health (NIMH); Weill Medical College of Cornell... and other collaborators

Completed

A Pragmatic Trial of Two Strategies for Implementing an Effective eHealth HIV Prevention Program (Keep It Up! 3.0)

HIV/AIDS | Chlamydia | Gonorrhea

United States
New Jersey Physicians Advisory Group
AMTC & Associates

Recruiting

An Evaluation of the Yes You Can... Make Smart Choices Curriculum (YYC!)

Adolescent Health | Pregnancy in Adolescence

United States
Takeda

Recruiting

A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

Colorectal Cancer | Non-small Cell Lung Cancer (NSCLC) | Squamous Cell Cancer of Head and Neck (SCCHN)

Korea, Republic of, United States, Australia
Ann & Robert H Lurie Children's Hospital of Chicago

Completed

The Laryngeal Mask Airway (LMA) Unique and the Air-Q Intubating Laryngeal Airway (ILA) in Pediatric Patients

Children

United States
Europainclinics z.ú.
Slovak Academy of Sciences

Active, not recruiting

EuroPainClinicsStudy XIr-Zj (EPCS XIr-Zj)

Back Pain

Slovakia
Millennium Pharmaceuticals, Inc.

Completed

A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors

Neoplasms, Advanced Solid

Netherlands
Takeda
Nimbus Lakshmi, Inc.; Innovaderm Research Inc.

Completed

Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

United States, Canada
Takeda

Completed

A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male Participants

Healthy Volunteers

Japan
sherine Hosny Mohamed Gad Allah

Unknown

JZ Thickness as a Predictor of Recurrent Unexplained First Trimesteric Pregnancy Loss. (JZ)

Patients With Recurrent Unexplained Pregnancy Loss

Egypt
W.L.Gore & Associates

Recruiting

Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms (TAMBE)

Thoracoabdominal Aortic Aneurysm

United States, United Kingdom
Associació per a la Recerca Oncologica, Spain
Takeda; Pivotal S.L.

Unknown

Paclitaxel and TAK-228 in Urothelial Carcinoma

Metastatic Urothelial Cancer

Spain
European Organisation for Research and Treatment...

Withdrawn

TAK-700 in Castration Resistant Prostate Cancer

Prostate Cancer

Belgium
Takeda

Completed

Double Blind Comparative Study of TAK-875

Diabetic Patients

Japan
China Medical University Hospital

Unknown

Inherited Myokymia: A Clinical and Genetic Study of a Family

A Study of Clinical and Genetic Mutations in a Family of Neuromyotonia, so Called Isaac's Syndrome

Taiwan
W.L.Gore & Associates

Available

Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of the Thoracoabdominal and Pararenal Aortic Aneurysms (TAMBE) (TAMBE)

Thoracoabdominal Aneurysm

United States
The Second Hospital of Tangshan
Chinese PLA General Hospital

Completed

The Dorsal Homodigital Island Flap Based on the Dorsal Branch of the Digital Artery: A Review of 171 Cases

Soft Tissue Defect | Sensory Reconstruction of Digits | Multiple Digital Defects

China
Takeda
Richmond Pharmacology Limited

Completed

Safety, Tolerability, and Pharmacokinetics of TAK-438 in Healthy Western Male Subjects, Preliminary Food Effect Analysis, and an Ethnic Comparison With Japanese Subjects

Dose Finding Study
The University of Hong Kong
Haven of Hope Hospital; The Social Innovation and Entrepreneurship Development...

Completed

Tablet-based Interactive Games in Elderly With Cognitive Impairment and Persons With Intellectual Disability

Intellectual Disability | Technology | Cognitive Impairments

Hong Kong

Search clinical trials for: TAk-935

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations